Gamco Investors INC. ET AL Has $8,395,000 Position in STERIS PLC (STE)
Gamco Investors INC. ET AL continued to hold its stake in shares of STERIS PLC (NYSE:STE) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 103,000 shares of the medical equipment provider’s stock at the end of the second quarter. Gamco Investors INC. ET AL owned about 0.12% of STERIS PLC worth $8,395,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in STE. BlackRock Inc. increased its stake in shares of STERIS PLC by 16,597.1% in the first quarter. BlackRock Inc. now owns 5,272,105 shares of the medical equipment provider’s stock worth $366,200,000 after buying an additional 5,240,530 shares during the period. Wellington Management Group LLP increased its stake in shares of STERIS PLC by 77.8% in the first quarter. Wellington Management Group LLP now owns 6,529,610 shares of the medical equipment provider’s stock worth $453,547,000 after buying an additional 2,856,744 shares during the period. Bessemer Group Inc. increased its stake in shares of STERIS PLC by 944,971.1% in the second quarter. Bessemer Group Inc. now owns 1,342,001 shares of the medical equipment provider’s stock worth $109,373,000 after buying an additional 1,341,859 shares during the period. American Century Companies Inc. increased its stake in shares of STERIS PLC by 18.9% in the first quarter. American Century Companies Inc. now owns 2,071,740 shares of the medical equipment provider’s stock worth $143,903,000 after buying an additional 328,635 shares during the period. Finally, Harbour Capital Advisors LLC purchased a new stake in shares of STERIS PLC during the second quarter worth about $3,750,000. 92.40% of the stock is currently owned by hedge funds and other institutional investors.
Shares of STERIS PLC (NYSE:STE) opened at 84.98 on Tuesday. STERIS PLC has a one year low of $63.80 and a one year high of $87.49. The stock has a market capitalization of $7.24 billion, a P/E ratio of 60.79 and a beta of 1.33. The company’s 50-day moving average is $83.21 and its 200-day moving average is $75.80.
STERIS PLC (NYSE:STE) last announced its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The company had revenue of $608 million for the quarter, compared to analysts’ expectations of $597.66 million. STERIS PLC had a net margin of 4.63% and a return on equity of 11.39%. STERIS PLC’s revenue was down 4.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.79 EPS. On average, equities research analysts anticipate that STERIS PLC will post $4.06 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be paid a $0.31 dividend. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 1.46%. The ex-dividend date of this dividend is Friday, August 25th. STERIS PLC’s payout ratio is currently 80.00%.
A number of analysts recently issued reports on STE shares. Zacks Investment Research raised shares of STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price target on the stock in a report on Tuesday, July 11th. Wellington Shields downgraded shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. KeyCorp raised shares of STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price target on the stock in a report on Wednesday, May 3rd. BidaskClub downgraded shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Raymond James Financial, Inc. increased their price target on shares of STERIS PLC from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $86.75.
In other STERIS PLC news, VP Sudhir K. Pahwa sold 800 shares of the business’s stock in a transaction on Thursday, May 25th. The shares were sold at an average price of $77.28, for a total value of $61,824.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $80.05, for a total transaction of $800,500.00. The disclosure for this sale can be found here. Insiders sold a total of 46,354 shares of company stock worth $3,805,772 over the last three months. 2.55% of the stock is currently owned by corporate insiders.
STERIS PLC Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Stock Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related stocks with our FREE daily email newsletter.